Esaote focuses on medical diagnostic imaging, specifically in ultrasound, MRI, and healthcare IT, self-described as contributing to better quality healthcare.

Esaote

ATEC Spine is a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, self-described as focusing on surgical techniques and technology.

ATEC Spine

SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. It offers orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical spine. The company's orthobiologics products include demineralized bone matrix (DBM), collagen ceramic matrices, demineralized cancellous allograft bone products, and synthetic bone void fillers to improve bone fusion rates in a range of orthopedic surgeries, including spine, hip, and extremities procedures. It also offers orthobiologics products in various forms, such as fibers, putties, pastes, strips, and DBM. In addition, the company offers implant products for spinal decompression, alignment, stabilization, and image-guided surgical solutions, as well as a surgical navigation system used to facilitate fusion in degenerative, minimally invasive, and complex spinal deformity procedures throughout the lumbar, thoracic, and cervical regions of the spine. SeaSpine Holdings Corporation was incorporated in 2015 and is headquartered in Carlsbad, California.

SeaSpine Holdings Corporation

Casa di Cura Privata San Rossore is a private healthcare facility that provides medical services, including diagnostic pathways and specialized units for various medical needs. The facility offers inpatient services and caters to both national and international patients.

Metric
Company Name	Esaote	ATEC Spine	SeaSpine Holdings Corporation	Casa di Cura Privata San Rossore
Symbol			SPNE
MSH ID	COM:ESAOTE	COM:ALPHATECSPINE	COM:SEASPINE	IT:CASADICURASANROSSORE
Market	PRIVATE	PRIVATE	STOCKS	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services	Healthcare	Healthcare & Health Services
Industry	Medical Devices	Medical Devices	Medical - Devices	Healthcare
Country	IT	US	US	IT
Stage		Post-IPO Equity
Employee Count	1.00K		523
Website	esaote.com	alphatecspine.com	seaspine.com	casadicurasanrossore.it
LinkedIn
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	35.69K	11.77K	1.86K	34.07K
Web Traffic Growth	-0.52	-0.08	-0.23	2.20
Valuation
Raised Capital		150M

Metric
Revenue			191.45M
Revenue (LTM)
Revenue (NTM)
Gross Profit			114.59M
EBITDA			-55.45M
Operating Income			-60.98M
Net Income			-54.35M
EPS			-1.62
Diluted EPS			-1.62
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin			0.60
Operating Profit Margin			-0.32
EBITDA Margin			-0.29
Net Profit Margin			-0.28
Return on Equity			-0.22
Return on Assets			-0.14
Return on Capital Employed			-0.19

COM:ESAOTE

Esaote

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio			-7.67
P/B Ratio			1.29
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple			-1.35

Metric
Days Sales Outstanding			81.67
Days Payables Outstanding			98.11
Days Inventory Outstanding			343.32
Operating Cycle			412.40
Cash Conversion Cycle			315.99
Asset Turnover			0.51

Metric
Operating Cash Flow			-33.51M
Free Cash Flow			-59.55M
Cash Flow to Debt			-4.14
Operating Cash Flow/Sales			-0.18
Free Cash Flow Yield

Metric
Cash & Equivalents			83.11M
Accounts Receivable			-7.93M
Inventory			72.30M
Goodwill			84.59M
Debt to Capitalization			0.03
Debt to Assets			0.12
Current Ratio			3.18
Quick Ratio			2.25

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue			0.06
R&D to Revenue			0.10
SG&A to Revenue			0.22